Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04420689 · ClinicalTrials.gov registry record · Phase 1
Bevonescein to Highlight Nerves in Patients Undergoing Head & Neck Surgery
A Phase 1 study, sponsored by Alume Biosciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 27
- Enrollment target
NCT04420689 is a Phase 1 study that has completed, run by Alume Biosciences. The registered enrollment target is 27 participants.
The verdict
NCT04420689, a Phase 1 study, has completed, sponsored by Alume Biosciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 27 participants
- Enrollment target
Study Summary
Bevonescein to Highlight Nerves in Patients Undergoing Head \& Neck Surgery
Interventions
- DRUG Bevonescein
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2020-06-18 |
| Est. Completion | 2022-02-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04420689
The ClinicalTrials.gov registry entry for NCT04420689 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alume Biosciences, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bevonescein is the first listed.
NCT04420689 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04420689 about?
NCT04420689 is a clinical study titled "Bevonescein to Highlight Nerves in Patients Undergoing Head & Neck Surgery". Bevonescein to Highlight Nerves in Patients Undergoing Head \& Neck Surgery
What is the current status of trial NCT04420689?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2020-06-18. Estimated completion is 2022-02-15.
What interventions are being tested in trial NCT04420689?
The interventions under investigation include: Bevonescein (DRUG).
Who is sponsoring clinical trial NCT04420689?
This trial is sponsored by Alume Biosciences, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.